Alan Vickery

About Alan Vickery

Alan R. Vickery is a Products Liability Partner residing in our Dallas, Texas office. Alan’s practice focuses on defending pharmaceutical and medical device companies in mass tort and products liability litigations in federal and state courts across the country. Read Alan's full bio

Impact of President Trump’s Opioid Legislation on Drug Manufacturers

President Trump recently signed the SUPPORT, or Substance-Use Disorder Prevention That Promotes Opioid Recovery and Treatment, for Patients and Communities Act (the “Act”), aimed at curbing the overuse of opioids in the United States. The Act is far-reaching, and it includes changes to Medicare, Medicaid and other public health efforts. Certain sections, especially those in Title III, “FDA and Controlled Substance Provisions,” will have a direct impact on manufacturers of certain products used to treat chronic pain.

Continue reading